Biological Production 2009

Venue: London

Location: London, United Kingdom

Event Date/Time: Sep 21, 2009 End Date/Time: Sep 22, 2009
Report as Spam


SMi's inaugural Biological Production conference looks to address the main areas of the production of biological products, process scale-up and validation, comparability issues and technology transfer, with a series of case studies from industry leaders. Hear methods for the development of an integrated approach to your mammalian cell line development from Pfizer, the utilisation of scale process models in your process scale-up from BTG and the importance of communication in technology transfer from Novartis.


Additional Information

Hear keynote addresses from: • Arindam Bose, Executive Director of Biologics Strategy & Alliances, Worldwide Pharmaceutical Sciences, Pfizer Global Biologics • Stephen Taylor, VP Business Development, Avecia • John Mott, Director, Bioprocess R&D, Cell Line Development, Global Biologics, Pfizer Our expert speaker line-up also includes: • Mark Bustard, Technical Manager, bioProcessUK • Chris Hewitt, Professor of Pharmaceutical Engineering, Loughborough University • Jens Lohrmann, Principal Scientist, Analytical R&D, Novartis • Richard Francis, Director, Process Science, BTG • Bernard Chan, Chief Business Officer, CMC Biologics • Robin Thorpe, Head, Biotherapeutics Group, National Institute for Biological Standards and Control PLUS A FULL DAY POST-CONFERENCE WORKSHOP A Quality by Design (QbD) Framework for Biopharmaceutical Glycosylation During Production 23rd September 2009, Copthorne Tara Hotel, London, UK In Association with: Ludger UK